SCHEDULE: Janus Henderson Discloses 8.2% Stake in Biomea Fusion
Beneficial Ownership Report
Janus Henderson Group plc has reported a beneficial ownership of 8.2% in Biomea Fusion, Inc., holding 3,750,000 shares of common stock.
Summary
- Janus Henderson Group plc, a Jersey-based entity, has filed a Schedule 13G indicating beneficial ownership in Biomea Fusion, Inc.
- The reporting person, Janus Henderson Group plc, beneficially owns 3,750,000 shares of Biomea Fusion, Inc. Common Stock.
- This ownership represents 8.2% of the class of securities, as detailed in Item 4(b) of the filing.
- Janus Henderson Group plc holds shared voting power and shared dispositive power over all 3,750,000 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Biomea Fusion, Inc.
- JHIUS, JHIUKL, and JHIAIFML, indirect subsidiaries of Janus Henderson, are registered investment advisers providing investment advice to Managed Portfolios.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently indicates a positive or negative sentiment regarding the issuer's performance or prospects. It is a standard regulatory report.
Positives
- The disclosure of a significant institutional stake by Janus Henderson Group plc may signal confidence in Biomea Fusion, Inc. to other investors.
- The acquisition of shares is stated to be in the ordinary course of business, indicating a standard investment rather than an activist position.
Risks
- The filing explicitly states that the securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer, mitigating immediate control-related risks for Biomea Fusion, Inc.
Future Outlook
The reporting person states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, suggesting a long-term, passive investment approach.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." Kristin Mariani, Head of North America Compliance, CCO.
Industry Context
This filing reflects ongoing institutional investment activity within the biotechnology sector, where significant stakes by asset managers like Janus Henderson are common as part of diversified portfolio strategies.
Stakeholder Impact
- Shareholders may view the increased institutional ownership by Janus Henderson Group plc as a positive indicator of confidence in Biomea Fusion, Inc.'s value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of execution of the Power of Attorney by Janus Henderson Group plc. |
| 2025-11-28 | Date of event which required the filing of this statement. |
| 2025-12-08 | Date of signature for the Schedule 13G filing by Kristin Mariani. |
Keywords
Biomea Fusion, Janus Henderson, Schedule 13G, institutional ownership, common stock, beneficial ownership, investment adviser, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.